Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Happy Valentines to our Board of Directors.

No....C'mon, you know what I mean. In this economic climate, and at this time , they need to preserve cash. Heck, TPL might need another loan. The scenario you talk about with 200mil shares already bought back and still 50 mil in the cash drawer is a no brainer.........would obviously mean we probably had a win in the courtroom, all patents received a NIRC and the PTO said thatis it with any more reexam requests. We are still potentially a long way from those victories. Simply put, the money is not there yet....the future is uncertain and as Badger put it.....we could not sustain the buyback program given the dynamics of the current market interest in PTSC. For the bod to even mention that they are thinking about it is foolish right now. It is not in the cards.

Share
New Message
Please login to post a reply